Literature DB >> 15155644

Mitogenicity of the recombinant mycobacterial 27-kilodalton lipoprotein is not connected to its antiprotective effect.

Avi-Hai Hovav1, Liuba Davidovitch, Gabriel Nussbaum, Jacob Mullerad, Yolanta Fishman, Herve Bercovier.   

Abstract

We reported previously that even though immunization with the recombinant mycobacterial 27-kDa lipoprotein (r27) induced a Th1-type response in mice, the vaccinated mice became more susceptible to challenge with Mycobacterium tuberculosis. In this study we show that r27 stimulates naive splenocytes to proliferate. Acylation of r27 was crucial for this effect, since a nonacylated mutant of r27, termed r27DeltaSP, failed to stimulate splenocytes either in vitro or in vivo. Depletion experiments indicated that only B cells were proliferating in a T-cell-independent manner. We also found that r27 is recognized by TLR2, which is involved in mitogenic stimulation. Interestingly, r27 but not r27DeltaSP induced high gamma interferon levels in splenocyte supernatants, whereas no significant interleukin-2 levels were detected. Since B-cell polyclonal activation might aggravate pathogen infection, we asked whether the antiprotective effect of the r27 lipoprotein is associated with its mitogenicity. We showed that, as in the case of r27, immunization of mice with the nonmitogenic r27DeltaSP lipoprotein resulted in increased M. tuberculosis multiplication. We conclude that the antiprotective effect of the r27 lipoprotein must be linked to properties of the polypeptide portion of the lipoprotein rather than to its lipid moiety and its mitogenicity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15155644      PMCID: PMC415711          DOI: 10.1128/IAI.72.6.3383-3390.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

Review 1.  Lymphocyte polyclonal activation: a pitfall for vaccine design against infectious agents.

Authors:  B Reina-San-Martin; A Cosson; P Minoprio
Journal:  Parasitol Today       Date:  2000-02

2.  Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors.

Authors:  H D Brightbill; D H Libraty; S R Krutzik; R B Yang; J T Belisle; J R Bleharski; M Maitland; M V Norgard; S E Plevy; S T Smale; P J Brennan; B R Bloom; P J Godowski; R L Modlin
Journal:  Science       Date:  1999-07-30       Impact factor: 47.728

3.  Lipopeptide presentation pathway in dendritic cells.

Authors:  A Hosmalin; M Andrieu; E Loing; J F Desoutter; D Hanau; H Gras-Masse; A Dautry-Varsat; J G Guillet
Journal:  Immunol Lett       Date:  2001-11-01       Impact factor: 3.685

4.  Discrimination of bacterial lipoproteins by Toll-like receptor 6.

Authors:  O Takeuchi; T Kawai; P F Mühlradt; M Morr; J D Radolf; A Zychlinsky; K Takeda; S Akira
Journal:  Int Immunol       Date:  2001-07       Impact factor: 4.823

5.  Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2.

Authors:  M Hirschfeld; C J Kirschning; R Schwandner; H Wesche; J H Weis; R M Wooten; J J Weis
Journal:  J Immunol       Date:  1999-09-01       Impact factor: 5.422

6.  Bacterial lipoprotein-based vaccines induce tumor necrosis factor-dependent type 1 protective immunity against Leishmania major.

Authors:  Javier Cote-Sierra; Amin Bredan; Carmen M Toldos; Benoit Stijlemans; Lea Brys; Pierre Cornelis; Manuel Segovia; Patrick de Baetselier; Hilde Revets
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

7.  Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection.

Authors:  J S Brown; A D Ogunniyi; M C Woodrow; D W Holden; J C Paton
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

8.  Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products.

Authors:  E Lien; T J Sellati; A Yoshimura; T H Flo; G Rawadi; R W Finberg; J D Carroll; T Espevik; R R Ingalls; J D Radolf; D T Golenbock
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

9.  Induction of direct antimicrobial activity through mammalian toll-like receptors.

Authors:  S Thoma-Uszynski; S Stenger; O Takeuchi; M T Ochoa; M Engele; P A Sieling; P F Barnes; M Rollinghoff; P L Bolcskei; M Wagner; S Akira; M V Norgard; J T Belisle; P J Godowski; B R Bloom; R L Modlin
Journal:  Science       Date:  2001-02-23       Impact factor: 47.728

10.  Antigens varying in affinity for the B cell receptor induce differential B lymphocyte responses.

Authors:  V Kouskoff; S Famiglietti; G Lacaud; P Lang; J E Rider; B K Kay; J C Cambier; D Nemazee
Journal:  J Exp Med       Date:  1998-10-19       Impact factor: 14.307

View more
  5 in total

1.  Gamma interferon and monophosphoryl lipid A-trehalose dicorynomycolate are efficient adjuvants for Mycobacterium tuberculosis multivalent acellular vaccine.

Authors:  Avi-Hai Hovav; Yolanta Fishman; Herve Bercovier
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 2.  Lipoproteins of bacterial pathogens.

Authors:  A Kovacs-Simon; R W Titball; S L Michell
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

3.  Infection with Porcine reproductive and respiratory syndrome virus stimulates an early gamma interferon response in the serum of pigs.

Authors:  Ronald D Wesley; Kelly M Lager; Marcus E Kehrli
Journal:  Can J Vet Res       Date:  2006-07       Impact factor: 1.310

4.  Roles of reactive oxygen species in CXCL8 and CCL2 expression in response to the 30-kDa antigen of Mycobacterium tuberculosis.

Authors:  Hye-Mi Lee; Dong-Min Shin; Kwang-Kyu Kim; Ji-Sook Lee; Tae-Hyun Paik; Eun-Kyeong Jo
Journal:  J Clin Immunol       Date:  2008-08-09       Impact factor: 8.317

5.  Potentiating effects of MPL on DSPC bearing cationic liposomes promote recombinant GP63 vaccine efficacy: high immunogenicity and protection.

Authors:  Saumyabrata Mazumder; Mithun Maji; Nahid Ali
Journal:  PLoS Negl Trop Dis       Date:  2011-12-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.